INO

MKT CAP:$105M

Inovio Pharmaceuticals Inc

Market Cap

$105M

Healthcare·Biotechnology·🇺🇸 United States·NASDAQ

Healthcare·Biotechnology·🇺🇸·NASDAQ

Stock Price

$1.07-$0.62 (-36.69%)

Jun 5, 2026

52W High $2.8752W Low $1.05

Company Details

Inovio Pharmaceuticals, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of DNA medicines to treat and protect people from diseases associated with human papillomavirus (HPV), cancer, and infectiou...

CEO

—

IPO Date

Feb 12, 1998

Website

www.inovio.com

Key Metrics TTM

Revenue

-$65.3K

-123.1% YoY

Net Income

-$85M

EPS (Diluted)

Free Cash Flow

-$84M

Revenue / Share

-$0.00

Gross Margin

4577.1%

Operating Margin

128126.3%

Net Margin

129981.8%

FCF Margin

127899.0%

P/S

P/E

Earnings Reports

Q2 2026

Aug 12, 2026

PENDING

Q1 2026

May 13, 2026

$0-100.0%

FY 2025

Mar 12, 2026

$65.3K-70.0%

Q4 2025

Mar 12, 2026

-$65.3K-155.9%

Q3 2025

Nov 10, 2025

Revenue & Profitability

Valuation

Operating Cash Flow

CapEx Spend

OpEx vs Revenue Growth (YoY)

Stock-Based Compensation

OpEx Breakdown

War Chest

Shares Outstanding

Revenue Per Employee

Revenue / Employee